About Mirakl: Founded in 2012, Mirakl has been at the forefront of marketplace innovation, empowering every business to compete in the platform economy. Today, Mirakl’s operating system combines an enterprise marketplace solution (Mirakl Platform) that enables
About Us Harmattan AI is a next-generation defense prime building autonomous and scalable defense systems. Following the close of a $200M Series B, valuing the company at $1.4 billion, we are expanding our teams and capabilities
Bioptimus is building the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovation in biomedicine. With more than $75M in funding, Bioptimus is a fast-growing start-up headquartered in Paris, incorporated in
The mission At Lucis, we believe healthcare should be preventive, not reactive. We’re building the OS for human longevity to help people add more healthy years to their lives. You can read more about who we
About Noïa Labs Noïa Labs is an early-stage neurotechnology company building the next generation of human-AI interfaces. Were tackling one of the most ambitious problems in human-AI interaction: decoding human intent directly from brain signals, in real time
Noïa Labs, based in Paris, is seeking a talented full-stack engineer to develop software for their innovative neural interface system. You will design real-time applications connecting neural signals to AI, working closely with ML engineers and neuroscientists
About the job Design, build, and scale production-grade AI systems that power the next generation of intelligent commerce. You will work at the intersection of Software Engineering, Machine Learning, and Generative AI to build AI-native products,
Making preventive health the default for every human in Europe The mission At Lucis, we believe healthcare should be preventive, not reactive. We’re building the OS for human longevity to help people add more healthy years
Bioptimus is building the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovation in biomedicine. With more than $75M in funding, Bioptimus is a fast‑growing start‑up headquartered in Paris, incorporated in
About us Owkin is an agentic AI company pioneering Biological Artificial Superintelligence to solve problems in biology where human researchers alone have failed. Owkin builds K Pro - an AI scientist for pharmaceutical research and strategic